UNITED STATES  
  SECURITIES AND EXCHANGE COMMISSION  
  Washington, D.C. 20549  
     

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.___)*

 

Avalanche Biotechnologies, Inc.

(Name of Issuer)

 

Common Stock, par value $.0001 per share

(Title of Class of Securities)

 

05337G 10 7

(CUSIP Number)

 

December 31, 2014

(Date of Event Which Requires Filing of this Statement)

 

 

  

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o Rule 13d-1(b)
o Rule 13d-1(c)
x Rule 13d-1(d)

 

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

 

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 6
 

 


 

 

CUSIP No.  05337G 10 7
 
  1.

Names of Reporting Persons

I.R.S. Identification No. of Above Persons (Entities Only)

 

Zygtech, LLC

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) o
    (b) o
 
  3.

SEC Use Only

 

 
  4.

Citizenship or Place of Organization

New Jersey

     

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

-0-

 
6.

Shared Voting Power*

2,563,176

 
7.

Sole Dispositive Power

-0-

 
8.

Shared Dispositive Power*

2,563,176

 
  9.

Aggregate Amount Beneficially Owned by Each Reporting Person*

2,563,176

 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11.

Percent of Class Represented by Amount in Row (9)**

11.26%

 
  12.

Type of Reporting Person (See Instructions)

OO

 

* See Item 4 below.
   

 

Page 2 of 6
 

   


 

 

CUSIP No.  05337G 10 7
 
  1.

Names of Reporting Persons

I.R.S. Identification No. of Above Persons (Entities Only)

 

Zygmunt Wilf

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) o
    (b) o
 
  3.

SEC Use Only

 

 
  4.

Citizenship or Place of Organization

United States

     

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

5.

Sole Voting Power

-0-

 
6.

Shared Voting Power*

2,563,176

 
7.

Sole Dispositive Power

-0-

 
8.

Shared Dispositive Power*

2,563,176

 
  9.

Aggregate Amount Beneficially Owned by Each Reporting Person*

2,563,176

 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11.

Percent of Class Represented by Amount in Row (9)**

11.26%

 
  12.

Type of Reporting Person (See Instructions)

IN

 

* See Item 4 below.
   

 

Page 3 of 6
 

 

Item 1.
  (a)

Name of Issuer

 

Avalanche Biotechologies, Inc.

  (b)

Address of Issuer’s Principal Executive Offices

 

1035 O’Brien Drive, Suite A

Menlo Park, CA 94025

 
Item 2.
  (a)

Name of Person(s) Filing

 

Zygtech, LLC and Zygmunt Wilf

  (b)

Address of Principal Business Office or, if none, Residence

 

820 Morris Turnpike, Suite 301

Short Hills, NJ 07078

  (c)

Citizenship

 

New Jersey (Zygtech, LLC) and United States (Zygmunt Wilf)

  (d)

Title of Class of Securities

 

Common Stock, $0.0001 per share

  (e)

CUSIP Number

 

05337G 10 7

 
Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable  

 

 Item 4. Ownership
 
 Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
 (a), (b), and (c)
 

 

Reporting

Persons

 Number of Shares With

Sole Voting and

Dispositive Power

 Number of Shares

With Shared Voting

and Dispositive

Power**

Aggregate

Number of

Shares

Beneficially Owned

 Percentage

of Class

Beneficially Owned**

Zygtech LLC -0- 2,563,176 2,563,176 11.26%
         
Zygmunt Wilf -0- 2,563,176 2,563,176 11.26%
         

 

*All shares are held in the name of Zygtech, LLC. Mr. Wilf is a member of, and controls, Zygtech, LLC.
**Based upon 22,754,037 shares of Common Stock outstanding as of January 2, 2015 as reported by the Issuer in its Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on January 5, 2015.

 

Page 4 of 6
 

 

   
Item 5. Ownership of Five Percent or Less of a Class  
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   o.  
   
Not applicable.  
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person  
Not applicable.  
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person  
Not applicable.  
   
Item 8. Identification and Classification of Members of the Group  
Not applicable.  
   
Item 9. Notice of Dissolution of Group  
Not applicable.  
     
Item 10. Certification  
Not applicable.  
       

 

Page 5 of 6
 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: January 31, 2015

 

 

 

 

  Zygtech, LLC
     
     
     
  By: /s/ Zygmunt Wilf
  Name: Zygmunt Wilf
  Title: Authorized Signatory
     
     
  By: /s/ Zygmunt Wilf
  Name: Zygmunt Wilf

 

Page 6 of 6